JUPITER, FL / ACCESSWIRE / April 30, 2019 / Dyadic International, Inc. (''Dyadic'') (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression ...

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity ...

FROM the wreck of one of Queensland’s biotech disappointments, drug-manufacturing lab says it is rapidly growing in a niche market. Luina Bio is based out of a plant in Brisbane’s western suburb of ...

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new senior executive ...

The Queensland government has thrown its weight behind the biotech sector in a bid to grow local jobs in the burgeoning industry. It will invest in Brisbane-based businesses Ellume and Luina Bio as ...

Add articles to your saved list and come back to them any time. A Brisbane startup says it can make the active ingredients for the new generation of mRNA vaccines in Australia, but more government ...

Dyadic International Inc (NASDAQ:DYAI) CEO Mark Emalfarb tells Proactive Investors the company has inked a worldwide sub-licensing pact with Luina Bio Pty Ltd, one of Australia's most experienced ...

Two new fully-funded R&D collaborations announced with academia and industry - November 2021 Research, license, and collaboration agreement executed with Janssen - December 2021 NIIMBL coronavirus ...

Luina Bio has extensive experience in manufacturing recombinant proteins, live therapeutics, whole cell vaccines, viral vaccines, purified plant extracts and pro-biotics for pre-clinical, phase 1 to 3 ...

The Queensland government has thrown its weight behind the biotech sector in a bid to grow local jobs in the burgeoning industry. It will invest in Brisbane-based businesses Ellume and Luina Bio as ...